Gregorio Emerson P, Grando Joao P, Saqueti Eufanio E, Almeida Silvio H, Moreira Horacio A, Rodrigues Marco A
Section of Urology, Department of Surgery, Health Sciences Center, State University of Londrina, UEL, Londrina, Parana, Brazil.
Int Braz J Urol. 2007 Mar-Apr;33(2):151-60. doi: 10.1590/s1677-55382007000200004.
Compare the capacity of the PSA density (PSAD), Free PSA percentage (%FPSA) and PSA transition zone density (PSATZ) in improving the sensitivity and specificity of the PSA to detect prostate cancer (PCa) in men with a PSA between 4 and 10 ng/mL.
One hundred and forty five men with PSA between 4 and 10 ng/mL were prospectively studied. Blood collection for the total PSA and free PSA was performed as well as transrectal ultra-sound with prostate biopsy and measurement of the total prostate volume (TPV) and transition zone volume (TZV). Patients with initial negative biopsy were followed and the prostate biopsy was repeated in those that presented PSA increase. The capacity of the PSAD, %FPSA and PSADTZ in improving the sensitivity and specificity pf the PSA test to the detection of the PCa was assessed by univariate and multivariate analyses and through the ROC curve.
Of the 145 patients, 38 (26.2%) had PCa and in 107 (73.8%) a benign prostate disease was diagnosed. No difference among the PSAD, %FPSA and PSADTZ was found. The multivariate analysis showed that the PSADTZ, %FPSA, TZV and age were those more powerful and highly significant PCa predictors.
The determination of %FPSA and PSAD can allow a better discrimination between PCa and benign disease that the isolated use of PSA. The combination of PSADTZ, %FPSA, TZV and age promote a high accuracy for PCa detection.
比较前列腺特异抗原密度(PSAD)、游离前列腺特异抗原百分比(%FPSA)和前列腺移行区密度(PSATZ)在提高前列腺特异抗原(PSA)检测4至10 ng/mL男性前列腺癌(PCa)的敏感性和特异性方面的能力。
对145例PSA在4至10 ng/mL之间的男性进行前瞻性研究。采集总PSA和游离PSA的血液样本,同时进行经直肠超声引导下前列腺活检,并测量前列腺总体积(TPV)和移行区体积(TZV)。对初始活检阴性的患者进行随访,对PSA升高的患者重复进行前列腺活检。通过单因素和多因素分析以及ROC曲线评估PSAD、%FPSA和PSADTZ在提高PSA检测PCa的敏感性和特异性方面的能力。
145例患者中,38例(26.2%)患有PCa,107例(73.8%)被诊断为良性前列腺疾病。未发现PSAD、%FPSA和PSADTZ之间存在差异。多因素分析显示,PSADTZ、%FPSA、TZV和年龄是更有力且高度显著的PCa预测因素。
与单独使用PSA相比,测定%FPSA和PSAD能够更好地区分PCa和良性疾病。PSADTZ、%FPSA、TZV和年龄的联合应用可提高PCa检测的准确性。